Laboratoire WatchFrog is the 1st privately owned laboratory in Europe 100% dedicated to endocrine disruptor assessment. Founded in 2005 and headquartered in France, the company has been operating for 14 years. Their mission is to provide data that contributes to evaluating the security of compounds, products, packaging, and water samples in relation to endocrine disruptor topics. Laboratoire Watchfrog offers tailor-made evaluation strategies and protocols, considering the specific context and needs of their clients. The company operates in the Biotechnology industry and received a $1.50M Venture Round investment on 21 March 2015 from Groupe Chevrillon as its last recorded investment.
No recent news or press coverage available for Laboratoire WatchFrog.